Back to ENTA
VANGUARD GROUP INC ENTA Position History
Enanta Pharmaceuticals, Inc. • Healthcare
Quarters held
12
Latest value
$290K
Q4 2025
Peak value
$33.4M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $47K |
| Q1 2025 | $11M |
| Q1 2025 | $39K |
| Q2 2025 | $64K |
| Q2 2025 | $14.8M |
| Q2 2025 | $114K |
| Q3 2025 | $1.4M |
| Q3 2025 | $84K |
| Q3 2025 | $21.7M |
| Q4 2025 | $2.6M |
| Q4 2025 | $33.4M |
| Q4 2025 | $290K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $290K | 18.4K | — | — |
| Q4 2025 | $33.4M | 2.12M | — | — |
| Q4 2025 | $2.6M | 164.4K | — | — |
| Q3 2025 | $21.7M | 1.81M | — | — |
| Q3 2025 | $84K | 7.0K | — | — |
| Q3 2025 | $1.4M | 120.2K | — | — |
| Q2 2025 | $114K | 15.1K | — | — |
| Q2 2025 | $14.8M | 1.95M | — | — |
| Q2 2025 | $64K | 8.4K | — | — |
| Q1 2025 | $39K | 7.0K | — | — |
| Q1 2025 | $11M | 1.99M | — | — |
| Q1 2025 | $47K | 8.5K | — | — |